Medicare GLP-1 Coverage Expansion Delayed Indefinitely
The proposed BALANCE model to cover GLP-1 medications for weight loss under Medicare has been delayed indefinitely, impacting beneficiaries who were expecting expanded coverage. A temporary Bridge program will extend coverage through July 2026 and is now extended until 2027 but does not count toward Part D deductibles or out-of-pocket maximums.

Topics: GLP-1 medications healthcare policy Medicare coverage